Stage 2 Stocks in Healthcare Plans
6 US stocks in Healthcare Plans are in Stage 2, the advancing phase of Weinstein's stage analysis. Listed below: those priced at $5 or more and trading at least $1 million a day on average, ranked by setup score and updated after every close (last close Oct 23, 2026).
| Stock | Close | 1D | Setup | Weeks in stage |
|---|---|---|---|---|
| HUM Humana Inc. | $422.07 | +0.26% | 7.8 | 2 |
| CNC Centene Corporation | $70.17 | -1.50% | 7.8 | 1 |
| CI The Cigna Group | $306.95 | -2.83% | 7.3 | 1 |
| ELV Elevance Health, Inc. | $439.95 | -1.20% | 6.6 | 6 |
| OSCR Oscar Health, Inc. Class A | $30.99 | -6.99% | 6.6 | 22 |
Healthcare Plans: quick answers
Which stocks in Healthcare Plans are in an uptrend?
As of Oct 23, 2026, 6 US stocks in Healthcare Plans are in Stage 2, the uptrend phase. They are Elevance Health, Cigna Group, Humana, Centene and Oscar Health.
How many stocks in Healthcare Plans are in Stage 2?
6 of the 11 stocks we track in Healthcare Plans (54.5%) are in Stage 2. 4 are topping in Stage 3 and 1 is in a Stage 4 downtrend. That share has risen 18.2 points over the last 20 sessions.
Which stocks in Healthcare Plans entered Stage 2 recently?
3 stocks entered Stage 2 in the last four weeks: Centene (its first week), Cigna Group (its first week) and Humana (week 2).
Daily screens
Every one recalculated after the close, with the exact criteria published on the page.
Stage 2 in other sectors & industries
US stocks in a confirmed uptrend (Stage 2, Weinstein’s advancing phase), grouped by sector and industry and ranked by setup score.